Tax planning for rheumatologists with practice equity
Rheumatology K-1 income from infusion practices needs different tax structure than pure E/M income.
Author: Pouyan Golshani
Founder of GigHz. Physician, builder, and deep-tech advisor exploring the intersections of advanced materials, medicine, and market strategy. I help innovators refine ideas, connect to the right stakeholders, and bring meaningful solutions to life — one signal at a time.
Biologic infusion economics for rheumatology practices
Rheumatology infusion centers are a quiet PE target. Here’s the buy-and-bill economics that drive the practice valuation.
Sleep lab economics within a pulmonary practice
Sleep lab ownership is a clean economic add to a pulmonary practice. Here’s the modeling and the regulatory landscape.
AI tools for pulmonology: PE triage, lung nodule, and CDS
Pulmonology AI has clinical evidence weight in PE triage and lung nodule management. Here’s the working directory.
Real estate for pulmonologists
Pulmonary income supports a real estate build. Here’s the framework.
Tax planning for pulmonologists with mixed income streams
Pulmonology compensation often mixes outpatient E/M, procedures, ICU, and sleep. Here’s how the tax structure should reflect that mix.
Pulmonary practice economics: PFT lab, sleep, bronchoscopy, and ICU revenue streams
Pulmonologists straddle four revenue streams that most never optimize together. Here’s the practice structure conversation.
Referral leakage in oncology: PCP and surgical inbound dynamics
Oncology referral patterns are volatile. Here’s how to measure inbound leakage and capture it.
AI tools for oncology: precision oncology, biomarker matching, and CDS
Oncology AI is dense and moving fast. Here’s the directory of tools with real deployment data.
Real estate for oncologists: practice property + personal portfolio
Oncology practice owners often own their building. Here’s how to layer that with a personal real estate portfolio.